Health
Astrazeneca’s New COVID Antibody Drug Promises Instant Coronavirus Immunity Enters Phase 3 Trials – Tech Times
If proven effective, this would be another breakthrough from Astrazeneca.
Scientists from the University College London Hospitals NHS Trust (UCLH) are studying the possibility of providing instant long-term immunity to patients who are at higher risk. The new COVID antibody drug developed by pharmaceutical giant Astrazeneca promises to give instant protection against SARS-COV-2, the virus causing the deadly COVID-19 that transformed the world in 2020.
If proven effective, this would be another breakthrough from Astrazeneca, which is still waiting for the approval from…
-
Noosa News17 hours agoOnly person charged over Spear Creek murders admits he lied to police
-
Noosa News19 hours agoAllegedly armed man who sparked hours-long lockdown of Brisbane City Botanic Gardens in custody
-
Business21 hours agoGold price races towards US$4,200 on Tuesday
-
General17 hours agoSouth Sydney Rabbitohs player Tyrone Munro charged with domestic violence offences